Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

MYL:US

53.1500 USD 1.7350 3.16%

As of 20:10:00 ET on 01/30/2015.

Snapshot for Mylan Inc/PA (MYL)

Open: 54.2500 Day's Range: 53.0100 - 55.0000 Volume: 6,399,419
Previous Close: 54.8850 52wk Range: 42.4300 - 59.6000 1-Yr Rtn: +17.04%

Stock Chart for MYL

No chart data available.
  • MYL:US 53.1500
  • 1D
  • 1M
  • 1Y
54.8850
Interactive MYL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYL

Current P/E Ratio (ttm) 18.0040
Estimated P/E(12/2014) 14.9130
Relative P/E vs. SPX 1.0248
Earnings Per Share (USD) (ttm) 2.9521
Est. EPS (USD) (12/2014) 3.5640
Est. PEG Ratio 1.1887
Market Cap (M USD) 19,892.64
Shares Outstanding (M) 374.27
30 Day Average Volume 3,320,753
Price/Book (mrq) 5.8706
Price/Sale (ttm) 2.6717
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 07/17/2007
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYL

Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Robert J CouryChairmanRodney L PiattVice Chairman
Heather BreschChief Executive OfficerRajiv MalikPresident
More Company Profile & Key Executives for MYL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil